Principal Investigators: David Goldfarb, PhD
Filament BioSolutions Inc. is a company focused on the development and commercialization of a portfolio of clinical nutrition products. The company applies scientific rigor and evidence-based clinical development principles to establish efficacy and confirm safety of its products. Its primary focus is on therapeutic areas that have a clear unmet need for clinical nutrition therapies, including supportive care oncology, urological, and gastrointestinal disorders. Filament BioSolutions utilizes a bespoke development approach driven by the optimal regulatory pathway for each product.